Shandong Buchang Pharmaceuticals Co Ltd603858
▲ ポジティブ資本関連度
Wholly owned subsidiary Tonghua Guhong acquires Angong Niuhuang Wan production approval and technology for 9.4 million yuan, expanding its product portfolio.

歩長製薬は9月29日、全額出資子会社の通化谷紅が吉林省天泰薬業股份有限公司と技術譲渡契約を締結し、安宮牛黄丸の製造承認と技術所有権を譲り受けると発表した。譲渡価格は940万元。2026年中間期の売上高は50億300万元、親会社株主に帰属する純利益は5億300万元だった。
Shandong Buchang Pharmaceuticals Co LtdWholly owned subsidiary Tonghua Guhong acquires Angong Niuhuang Wan production approval and technology for 9.4 million yuan, expanding its product portfolio.
Jilin Tiantai Pharmaceutical transfers ownership of its Angong Niuhuang Wan production approval and technology for 9.4 million yuan.
Tonghua Guhong, Buchang's wholly owned subsidiary, is the acquirer of the Angong Niuhuang Wan production approval and technology.